What an FDA drug or biologic submission contains
How INDs, NDAs, ANDAs and biologics license applications are built under 21 CFR Parts 312, 314 and 601, and how FDA reviews them.
3 posts
How INDs, NDAs, ANDAs and biologics license applications are built under 21 CFR Parts 312, 314 and 601, and how FDA reviews them.
What a manufacturer files under Regulation (EU) 2017/745: Annex II and III technical documentation, the route by class and how notified bodies review it.
What goes into a 510(k), De Novo, PMA or HDE submission to FDA, with format rules and review timeframes.